Decreased serum PCSK9 levels after ischaemic stroke predict worse outcomes.

Luca LiberaleFabrizio MontecuccoIlaria CasettaSilva SeraceniAlessandro TrentiniMarina PadroniFranco DallegriFrançois MachEnrico FainardiFederico Carbone

Published in: European journal of clinical investigation (2016)

A decrease in PCSK9 levels was a predictor for poor outcome and increased MACEs after AIS. Additional studies targeting post-AIS PCSK9 levels and activity are required to clarify the prognostic and pathophysiological relevance of PCSK9 after AIS.

Keyphrases

low density lipoprotein
metabolic syndrome
type diabetes
cancer therapy
glycemic control